Merck
Cancer Patients Face Higher Risk for Shingles
People newly diagnosed with cancer, particularly hematologic cancers, and those treated with chemotherapy have a ...
JANUARY 4, 2019
FDA Allows Expanded Use of Gardasil 9
The FDA approved an expanded use for Gardasil 9 for use in older men and women from 27 to 45 years. The HPV vaccine ...
OCTOBER 30, 2018
FDA Approves HCC Indication for Lenvima
The FDA approved a new indication for Lenvima for first-line treatment of patients with unresectable hepatocellular ...
AUGUST 20, 2018
FDA Modifies UC Indications of Pembrolizumab, Atezolizumab
The FDA modified the urethal cancer indications of Keytruda and Tecentriq, limiting their use to patients who are ...
JULY 9, 2018
FDA Approves Prevymis for CMV Prevention in Allo-HCT Patients
The FDA approved Merck's Prevymis, Merck for prophylaxis of cytomegalovirus infection and disease in adult ...
NOVEMBER 13, 2017
FDA Halts 3 MM Studies Evaluating Keytruda Combo
The FDA determined that the available data indicated that the risks of pembrolizumab, the company’s ...
JULY 6, 2017
